Findings challenge common practice regarding glucose control for critically ill patientsAugust 27, 2008An analysis of randomized trials indicates that for critically ill adults, tight glucose control is not associated with a significantly reduced risk of death in the hospital, but is associated with an increased risk of hypoglycemia, calling into question the recommendation by many professional societies for tight glucose control for these patients, according to an article in the August 27 issue of JAMA. In 2001, a randomized controlled trial (van den Berghe et al) showed that tight glucose control for critically ill surgical patients reduced hospital mortality by one-third. "Because few interventions in critically ill adult patients reduce mortality to this extent, the results of this trial were enthusiastically received and rapidly incorporated into guidelines," the authors write. Numerous organizations, including the American Diabetes Association and the American Association of Clinical Endocrinologists now recommend tight glucose control in all critically ill adults. "These recommendations have led to worldwide adoption of tight glucose control in a variety of intensive care unit (ICU) settings." But some subsequent trials of tight glucose control in certain ICU settings have failed to show the mortality benefit, and have indicated an increased risk for hypoglycemia (abnormally low blood sugar level). Renda Soylemez Wiener, M.D., M.P.H., of the Department of Veterans Affairs Medical Center, White River Junction, Vt., and Dartmouth Medical School, Hanover, N.H., and colleagues conducted a meta-analysis of 29 randomized controlled trials, examining the risks and benefits of tight glucose control (glucose goal less than 150 mg/dL) as compared with usual care in critically ill adults. The meta-analysis included data for 8,432 patients.
The researchers found that among these trials, there was no significant difference in hospital mortality between tight glucose control and usual care strategies (21.6 percent vs. 23.3 percent) and no significant difference in hospital mortality when stratified by surgical, medical, and medical-surgical ICU setting. Tight glucose control was not associated with a significantly decreased risk for new need for dialysis (11.2 percent vs. 12.1 percent), but was associated with a significantly decreased risk of septicemia (10.9 percent vs. 13.4 percent; generalized illness due to bacteria in the bloodstream). The risk of hypoglycemia was increased about 5-fold (13.7 percent vs. 2.5 percent). "Given the overall findings of this meta-analysis, it seems appropriate that the guidelines recommending tight glucose control in all critically ill patients should be re-evaluated until the results of larger, more definitive clinical trials are available," the authors write. JAMA and Archives Journals | |||||||||||||||||||||
|
Related Glucose Control Current Events and Glucose Control News Articles Mayo Clinic discovery may help diabetic gastric problem Mayo Clinic researchers have found what may provide a solution to one of the more troubling complications of diabetes -- delayed gastric emptying or gastroparesis. JDRF-funded clinical trial demonstrates continuous glucose monitoring improves blood sugar control Patients with type 1 diabetes who used continuous glucose monitoring (CGM) devices to help manage their disease experienced significant improvements in blood sugar control, according to initial results of a major multicenter clinical trial funded by the Juvenile Diabetes Research Foundation. Cognitive problems associated with diabetes duration and severity Individuals with mild cognitive impairment appear more likely to have earlier onset, longer duration and greater severity of diabetes, according to a report in the August issue of Archives of Neurology, one of the JAMA/Archives journals. Losing weight soon after type 2 diabetes diagnosis doubles positive outcomes People who lose weight soon after a diagnosis of type 2 diabetes have better control of their blood pressure and blood sugar, and are more likely to maintain that control even if they regain their weight, according to a Kaiser Permanente study published online in Diabetes Care, the American Diabetes Association journal. Growth hormone reduces abdominal fat, cardiovascular risk in HIV patients on antiviral therapy Low-dose growth hormone treatment reduced abdominal fat deposits and improved blood pressure and triglyceride levels in a group of patients with HIV lipodystrophy, a condition involving the redistribution of fat and other metabolic changes in patients receiving combination drug therapy for HIV infection. Disruption of blood sugar levels after heart surgery is common A study reveals today that inadequate blood sugar control in patients having heart surgery is associated with a four fold increase in post-surgery death and major complications - and that the blood sugar disturbances occur in patients with and without diabetes. Some patients may not need insulin for long-term control of type 2 diabetes Some patients with type 2 diabetes can control their disease for years yet avoid insulin injections by using multiple classes of oral diabetic medications, a new study found. An Australian-led diabetes study shows intensive glucose control reduces serious complications An Australian led global study, the largest of its kind, has found that the risk of developing serious kidney disease and other complications amongst our 1.2 million people living with diabetes can be significantly reduced by intensively lowering blood glucose (sugar) levels beyond what is currently standard practice. 100M pounds a year spent on self-monitoring in diabetes that may increase anxiety and depression The National Health Service (NHS) in the UK is spending £100 million a year to help people with non-insulin treated type 2 diabetes monitor their own blood sugar levels, but the process is more likely to make them depressed than provide any long-term health benefits, according to a series of articles published ahead of print on bmj.com today. People with diabetes may have all natural citrus supplement Two new studies presented at the Experimental Biology Annual Meeting suggest that an all-natural dietary supplement made from citrus may help people with type 2 diabetes lower their blood glucose numbers after a meal and their LDL-cholesterol levels. More Glucose Control Current Events and Glucose Control News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||